查看文章

Remote monitoring (RM) is a safe and effective alternative to in-office conventional follow-up.

We aimed to evaluate patient satisfaction with RM and its impact on healthcare resources in a population with cardiac implantable electronic devices.

Randomized, pragmatic, open-label controlled trial, with adult wearers of implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy with ICD (CRT-D), eligible for the CareLink® system. Patients newly implanted or with previous conventional follow-up were randomized to RM or conventional follow-up (control), and followed for 12 months, according to the centers’ practice. The number of in-office visits and adverse events were compared between groups. Patient and healthcare professionals’ satisfaction with RM were described.

Of the 134 randomized patients (69 RM; 65 control, aged 60±13 years), 80% were male …